hands this group has emerged as a very suitable protecting
group for both solution- and solid-phase synthesis.8 Instal-
lation of the Fmoc group to 12 using pyridine and FmocCl
(f 13) was followed by desilylation using 5 equiv of HF‚
py in THF14 to afford linker 4, ready for loading onto the
resin. Attachment of linker 4 to the hydroxymethyl-
substituted Merrifield resin 8 was achieved via formation of
trichloroacetimidate resin 7 and its activation with a catalytic
amount of TMSOTf (0.3 equiv) at 0 °C (Scheme 3).
Scheme 4a
Scheme 3a
a (a) (i) MeNH2, CH2Cl2, rt. (ii) Ac2O/pyridine, rt. (b) NEt3,
CH2Cl2, rt. (c) 0.3 equiv TMSOTf, 4 Å, CH2Cl2, 0 °C.
lamine until the generated UV spot completely disappeared.17
Solid-phase glycosylation with the Fmoc-bearing O-glucosyl
trichloroacetimidate 2 (3.0 equiv) at 0 °C and repetition of
the described sequence in a cyclic manner afforded resin-
bound oligosaccharides 16 (n ) 1-3) and 17 (n ) 1, 2).18
All glycosylations were performed only once with the
exception of the first one, which required repetition in order
to reach a complete â(1 f 4) linkage.19
The described solid-phase synthesis cycle was performed
three times. After each run preparative cleavage of the
polymer-bound structures 16 (n ) 1-3) using the conditions
described above16 furnished the corresponding oligosaccha-
rides 18, 19, and 1 in excellent yields (Scheme 5). Cellobiose
derivative 1820 was isolated in 85% overall yield over four
steps starting from 14 (96% per step). Up to the tetrameric
stage no significant drop in terms of efficiency of this new
a (a) 10 equiv CCl3CN, CH2Cl2, 0 °C. (b) (i) 0.3 equiv TMSOTf,
CH2Cl2, 0 °C. (ii) MeOH.
It is to be noted that conversion of 8 to 7 proceeds
smoothly and very quickly in a quantitative manner. The
reaction can be readily performed up to a 10-g scale, and
the resulting activated trichloroacetimidate polymer reagent
7 showed a high stability and was storable for at least 6
months.15 After linker attachment affording resin 14 the
remaining activated benzyl functions were quenched by direct
addition of methanol. Loading of resin 14 was determined
by a very fast and clean preparative cleavage of 15 by excess
MeNH2 (10 min) followed by acetylation to be 0.213 mmol/g
(Scheme 4).16 Under these conditions the linker was selec-
tively cleaved without affecting any O-acetyl groups; loading
was also determined by recycling unreacted linker molecule
4 from the washing solution.
(19) Solid-phase glycosylation to resin bound disaccharide 16 (n ) 1)
was repeated once under the same conditions.
(20) Analytical Data of Compound 18. MALDI-TOF (DHB/THF): m/z
calcd M (C32H42O17) 698.67; (M + Na)+ 721.66; (M + K)+ 737.77; found
721.9, 737.9. 1H NMR (600 MHz, CDCl3): δ 2.06 (m, 6 COCH3), 3.36 (s,
Generation of polymer-bound acceptor 3 was performed
by treatment with a mixture of dichloromethane and triethy-
3
3
(16) General Procedure for Cleavage. Dry resin was swollen in CH2-
Cl2 (10 mL/g resin), and the resulting suspension was shaken for 10 min
under an inert gas atmosphere. A solution of ∼8 M MeNH2 in EtOH (∼100
equiv) was added, and the resulting mixture was shaken for 10 min under
argon. The resin was rinsed off, switching three times between CH2Cl2
and THF. The evaporated filtrates were treated by a mixture of acetic
anhydride and pyridine (1:1, 20 mL/g) for 2 h. The resulting residues were
purified by flash chromatography.
(17) General Procedure for Deprotection. Dry resin was swollen in a
mixture of CH2Cl2/NEt3 (4:1), and the resulting suspension was shaken for
4 h. The resin was treated as described above and dried under high vacuum.
(18) General Procedure for Glycosylation. Dry acceptor loaded resin
was directly swollen in a CH2Cl2 solution (15 mL/g resin) containing donor
2 (3 equiv) and 4 Å molecular sieves. The resulting suspension was cooled
under argon to 0 °C and shaken for 10 min. A solution of a freshly prepared
0.5 M TMSOTf solution in CH2Cl2 (0.3 equiv) was added, and the resulting
mixture was shaken for 1 h under an inert gas atmosphere. The resin was
treated as described above.
OCH3), 3.55 (m, 5b-H), 3.65 (t, J ) 3.3 Hz, 4b-H), 3.71 (t, J ) 3.2 Hz,
4a-H), 3.87 (m, 5a-H), 4.13 (dd, J6,6′ ) 12.0 Hz, J5,6 ) 4.8 Hz, 6a-H), 4.27
3
3
(2d, J ) 3.7 Hz, 6′b-H, 6b-H), 4.49 (d, J1,2 ) 7.9 Hz, 1b-H), 4.50 (d, J
) 3.0 Hz, 6′a-H), 4.53-4.59 (m, CH2Ph), 4.80 (dd, J1,2 ) 3.7 Hz, J2,3
10.2 Hz, 2a-H), 4.84 (m, 2b-H), 4.85 (d, J1,2 ) 3.7 Hz, 1a-H), 5.19 (t, J
) 9.2 Hz, 3b-H), 5.43 (t, 3J ) 9.7 Hz, 3a-H), 7.21-7.31 (m, Ar). 13C NMR
(150.9 MHz, CDCl3): δ ) 62.2 (C-6a), 63.1 (C-6b), 65.4 (C-5a), 70.1 (C-
3a), 71.3 (C-2a), 72.5 (C-2b), 73.3 (C-5b), 75.5 (C-4b), 75.7 (C-3b), 77.0
(C-4a), 97.1 (C-1a), 101.1 (C-1b).
)
3
(21) Analytical Data of Compound 19. MALDI-TOF (DHB/THF): m/z
calcd M (C49H62O24) 1035.00; (M + Na)+ 1057.99; (M + K)+ 1074.10;
found 1057.3, 1073.3. 1H NMR (600 MHz, CDCl3): δ 2.03 (m, 8 COCH3),
3.36 (s, OCH3), 3.40 (m, 5b-H), 3.55 (m, 5c-H), 3.62 (m, 4b-H, 4c-H),
3.66 (m, 6b-H), 3.69 (m, 4a-H), 3.76 (d, 3J ) 7.3 Hz, 5a-H), 4.10 (m,
3
6′b-H), 4.13 (d, J ) 5.0 Hz, 6a-H), 4.17 (dd, J6,6′ ) 12.0 Hz, J5,6 ) 4.6
Hz, 6c-H), 4.34 (d, 2J ) 2.2 Hz, 6′c-H), 4.44 (d, J1,2 ) 7.9 Hz, 1b-H), 4.48
(d, J1,2 ) 7.9 Hz, 1c-H), 4.49 (d, 2J ) 2.1 Hz, 6′a-H), 4.53-4.59 (m, 2
CH2Ph), 4.80 (dd, J1,2 ) 7.9 Hz, J2,3 ) 6.2 Hz, 2b-H), 4.81 (m, 2a-H),
Org. Lett., Vol. 3, No. 5, 2001
749